샘플 요청 목록

 카트 문의
시장보고서
상품코드
1768417

임상시험수탁기관(CRO) 서비스 시장

Contract Research Organization Services (CROs)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 803 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 CRO(임상시험수탁기관) 서비스 시장은 2030년까지 1,491억 달러에 달할 전망

2024년에 814억 달러로 추정되는 세계의 CRO(임상시험수탁기관) 서비스 시장은 2024-2030년에 CAGR 10.6%로 성장하며, 2030년에는 1,491억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 임상 조사는 CAGR 11.4%를 기록하며, 분석 기간 종료시에는 767억 달러에 달할 것으로 예측됩니다. 초기 단계 개발 부문의 성장률은 분석 기간 중 CAGR 10.5%로 추정됩니다.

미국 시장은 324억 달러로 추정, 중국은 CAGR 13.6%로 성장 예측

미국의 CRO(임상시험수탁기관) 서비스 시장은 2024년에 324억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 101억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 13.6%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 8.7%와 9.5%로 예측됩니다. 유럽에서는 독일이 CAGR 10.6%로 성장할 것으로 예측됩니다.

세계의 CRO(임상시험수탁기관) 서비스 시장 - 주요 동향과 촉진요인 정리

CRO가 제약-바이오 산업에 필수적인 이유는?

임상시험 수탁기관(CRO)은 신약개발, 연구개발 및 상업화를 지원하는 연구 서비스 아웃소싱을 제공함으로써 제약 및 생명공학 산업에서 중요한 역할을 담당하고 있으며, 임상시험 관리, 전임상 연구, 약사법, 데이터 관리 등 다양한 서비스를 제공합니다. CRO와 협력함으로써 제약 및 생명공학 기업은 전문 지식, 첨단 기술, 세계 자원을 활용하여 신약 개발을 가속화하고 시장 출시 시간을 단축할 수 있습니다. CRO에 연구 활동을 위탁함으로써 기업은 핵심 역량에 집중하고 업무를 효율화할 수 있으며, CRO는 의약품 개발 생태계에 없어서는 안 될 존재가 되었습니다.

CRO 서비스 활용의 장점과 과제는?

CRO 서비스를 활용하면 비용 절감, 전문 지식에 대한 접근성, 업무 효율성 향상 등의 이점을 얻을 수 있으며, CRO의 규모와 경험으로 인해 사내 팀보다 더 비용 효율적으로 조사 활동을 수행할 수 있습니다. 또한 전 세계 임상시험 수행기관 네트워크와 규제에 대한 지식을 활용할 수 있으므로 다국가의 임상시험을 쉽게 수행할 수 있으며, 규제 요건을 준수할 수 있습니다. 그러나 CRO로의 아웃소싱은 효과적인 커뮤니케이션과 조정의 필요성, 데이터 보안에 대한 잠재적 위험, 조사의 품질과 무결성 보장 등 여러 가지 문제를 야기할 수 있습니다. 이러한 문제를 완화하고 CRO 서비스의 이점을 극대화하기 위해서는 강력한 파트너십과 명확한 계약 내용을 수립하는 것이 필수적입니다.

기술이 CRO 산업을 어떻게 변화시키고 있는가?

기술은 CRO 산업을 변화시키고 있으며, 임상시험 서비스의 효율성과 품질을 향상시키고 있습니다. 첨단 데이터 분석, 인공지능(AI), 머신러닝은 임상시험 설계, 환자 모집, 데이터 분석을 최적화하고 의약품 개발의 시간과 비용을 절감하기 위해 활용되고 있습니다. 전자 데이터 수집(EDC) 시스템과 원격 모니터링 툴은 데이터의 정확성을 높이고 임상시험의 진행 상황을 실시간으로 추적할 수 있도록 돕습니다. 원격의료 및 웨어러블 기기를 기반으로 한 분산형 임상시험(DCT) 모델의 채택은 특히 원격지나 소외된 지역에서 환자의 참여와 참여를 증가시키고 있습니다. 이러한 기술 발전은 CRO 업계의 혁신을 촉진하고 연구 서비스의 전반적인 효율성을 향상시키고 있습니다.

CRO 시장의 성장 동력은 무엇인가?

CRO 시장의 성장은 몇 가지 요인에 의해 이루어지고 있습니다. 의약품 개발의 복잡성과 비용 증가로 인해 제약 및 생명공학 기업은 연구 활동을 CRO에 위탁하고 있습니다. 데이터 관리 및 분석의 기술 발전으로 CRO 서비스의 역량과 효율성이 향상되고 있습니다. 임상시험의 세계화와 다양한 규제 요건을 충족해야 할 필요성도 국제적인 전문성을 갖춘 CRO에 대한 수요를 증가시키고 있습니다. 또한 맞춤형 의료의 부상, 생물제제 및 첨단 치료법의 개발은 이러한 분야에 특화된 CRO에 새로운 기회를 제공합니다. 이러한 요인들이 결합되어 CRO 시장의 지속적인 성장과 혁신을 보장하고 있습니다.

부문

서비스 유형(임상 연구, 초기 단계 개발, 실험실, 기타 서비스 유형); 치료 영역(암, 중추신경계 질환, 당뇨병, 심혈관질환, 대사성 질환, 감염증, 기타 치료 영역); 최종사용자(제약·바이오파마 기업, 의료기기 기업, 학술기관)

조사 대상 기업의 예

  • 360 biolabs(R)
  • Charles River Laboratories International Inc.
  • ICON plc
  • IQVIA, Inc.
  • KCR S.A
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • PSI CRO AG
  • Syneos Health, Inc.
  • WuXi AppTec

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 인도
  • 기타 아시아태평양
  • 라틴아메리카
  • 기타 지역

제4장 경쟁

KSA 25.07.17

Global Contract Research Organization Services (CROs) Market to Reach US$149.1 Billion by 2030

The global market for Contract Research Organization Services (CROs) estimated at US$81.4 Billion in the year 2024, is expected to reach US$149.1 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 Billion by the end of the analysis period. Growth in the Early Phase Development segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.4 Billion While China is Forecast to Grow at 13.6% CAGR

The Contract Research Organization Services (CROs) market in the U.S. is estimated at US$32.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.1 Billion by the year 2030 trailing a CAGR of 13.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Contract Research Organization Services (CROs) Market - Key Trends & Drivers Summarized

Why Are CROs Vital in the Pharmaceutical and Biotechnology Industries?

Contract Research Organizations (CROs) play a crucial role in the pharmaceutical and biotechnology industries by providing outsourced research services that support drug discovery, development, and commercialization. CROs offer a wide range of services, including clinical trial management, preclinical research, regulatory affairs, and data management. By partnering with CROs, pharmaceutical and biotech companies can access specialized expertise, advanced technologies, and global resources, accelerating the development of new therapies and reducing time-to-market. The ability to outsource research activities to CROs allows companies to focus on their core competencies and streamline their operations, making CROs an indispensable part of the drug development ecosystem.

What Are the Benefits and Challenges of Utilizing CRO Services?

The benefits of utilizing CRO services include cost savings, access to specialized expertise, and improved operational efficiency. CROs can conduct research activities more cost-effectively than in-house teams due to their scale and experience. They also provide access to a global network of clinical sites and regulatory knowledge, facilitating the conduct of multinational clinical trials and ensuring compliance with regulatory requirements. However, there are challenges associated with outsourcing to CROs, such as the need for effective communication and coordination, potential risks to data security, and ensuring the quality and integrity of research. Establishing strong partnerships and clear contractual agreements is essential to mitigate these challenges and maximize the benefits of CRO services.

How Is Technology Transforming the CRO Industry?

Technology is transforming the CRO industry, enhancing the efficiency and quality of research services. Advanced data analytics, artificial intelligence (AI), and machine learning are being used to optimize clinical trial design, patient recruitment, and data analysis, reducing the time and cost of drug development. Electronic data capture (EDC) systems and remote monitoring tools are improving data accuracy and enabling real-time tracking of clinical trial progress. The adoption of decentralized clinical trial (DCT) models, supported by telemedicine and wearable devices, is increasing patient participation and engagement, particularly in remote or underserved regions. These technological advancements are driving innovation in the CRO industry and improving the overall effectiveness of research services.

What Factors Are Driving the Growth in the CRO Market?

The growth in the CRO market is driven by several factors. The increasing complexity and cost of drug development are prompting pharmaceutical and biotechnology companies to outsource research activities to CROs. Technological advancements in data management and analytics are enhancing the capabilities and efficiency of CRO services. The globalization of clinical trials and the need to meet diverse regulatory requirements are also boosting demand for CROs with international expertise. Additionally, the rise of personalized medicine and the development of biologics and advanced therapies are creating new opportunities for CROs specializing in these areas. These factors collectively ensure the continued growth and innovation in the CRO market.

SCOPE OF STUDY:

The report analyzes the Contract Research Organization Services (CROs) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Clinical Research, Early Phase Development, Laboratory, Other Service Types); Therapeutic Area (Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Other Therapeutic Areas); End-Use (Pharma & Biopharma Companies, Medical Device Companies, Academic Institutes)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 307 Featured) -

  • 360biolabs(R)
  • Charles River Laboratories International Inc.
  • ICON plc
  • IQVIA, Inc.
  • KCR S.A
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • PSI CRO AG
  • Syneos Health, Inc.
  • WuXi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Contract Research Outsourcing: An Introduction
    • Qualities that have to be considered while selecting a CRO
    • Global Economic Update
    • Tariff Impact on Global Supply Chain Patterns
    • Competition
    • M&A Activity Rampant in the CRO Market
    • M&A Activity Yields Immense Pressure on Smaller CROs
    • Contract Research Organization Services (CROs) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Players Adapt & Align with Evolutionary Changes in CRO Industry
    • Global Market Prospects and Outlook
    • Global Contract Research Organization Services (CROs) Market Set for a Rapid Growth
    • Rapidly Changing & Evolving Landscape Entails Seismic Shifts for CROs
    • Stringent Regulations Fuel the Need for CROs
    • Technology Changes the Research Foot Prints of the CRO Industry
    • Market Outlook
    • Regional Market Analysis
    • Trend of Clinical Trials Outsourcing Attains Pace in North America
    • Digital Technology Facilitates Decentralized Trials
    • Key Trends in the CRO Market
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Rise in Pharmaceutical Sales to Drive Demand for CRO Services
    • Global Prescription Drug Sales (In US$ Trillion) for the Years 2017, 2019, 2021, 2023 & 2025
    • Persistent Increase in Pharmaceutical R&D Bodes Well for CRO Market
    • Surge in Clinical Trials Powers Growth of CRO Industry
    • CROs to Leverage Artificial Intelligence in a Major Way to Increase Efficacy of Clinical Research
    • Pandemic Spawns Digitization Wave
    • CROs and the Emergence of New Technology: Opportunities and Challenges
    • Popularity of Wearable technology Eases Enlisting Study groups and Tracking of Patient Activity
    • Biosimulation Enhances Data Interpretation and Pre-Verification
    • CROs: From a Humble Beginning to Partners of Moment for Drug Discovery Endeavors
    • Biotechnology Firms as Valuable Options
    • CROs in Great Demand
    • CROs with Process Maturity in Demand
    • Dealing with Geopolitical Issues
    • Decentralized Clinical Trials & Flexibility
    • Issues with Hybrid Trials & Sponsor Preferences
    • CROs to Mitigate Supply Chain Glitches
    • Bio-Pharmaceutical Sector Regains Momentum Post Pandemic
    • Growing Size and Complexity of Clinical Trials Increase Biotech's Dependence on CROs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Contract Research Organization Services (CROs) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Contract Research Organization Services (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Early Phase Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Early Phase Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Early Phase Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for CNS Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for CNS Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for CNS Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Metabolic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Metabolic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Metabolic Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Contract Research Organization Services (CROs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for India and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 197: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of World Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of World 15-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of World Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of World 15-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Infectious Diseases, Other Therapeutic Areas, Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases and Metabolic Diseases for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of World Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of World 15-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제